Ercelep O., Gümüş M. , "Comparison of clinicopathologic and survival characteristics of high grade endometrial cancers; single center experience.", CURRENT PROBLEMS IN CANCER, vol.-, 2018
Sevinc A., Ozkan M., Ozet A., Dane F., Oksuzoglu B., Isikdogan A., et al., "Biosimilar filgrastim vs filgrastim: a multicenter nationwide observational bioequivalence study in patients with chemotherapy-induced neutropenia", ONCOTARGETS AND THERAPY, vol.11, pp.419-426, 2018
Aygen B., Demir A., Gümüş M. , Karabay O., Kaymakoğlu S., Köksal A., et al., "Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report.", TURKISH JOURNAL OF GASTROENTEROLOGY, vol.29, pp.259-269, 2018
Inal A., Kodaz H., Odabas H., Duran A., Seker M., Inanc M., et al., "Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)", JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, vol.14, pp.578-582, 2018
Ercelep O., Ozcelik M., Gümüş M. , "Association of lymphadenectomy and survival in epithelial ovarian cancer.", CURRENT PROBLEMS IN CANCER, vol.-, 2018
Mutlu H., Bilican F., Mutlu H., Gümüş M. , "A comparison of metacognitive factors among patients with cancer and the control group.", PSYCHO-ONCOLOGY, vol.27, pp.1277-1283, 2018
Ercelep O., Ozdemir N., Turan N., Topcu T., Uysal M., Tanrıverdi O., et al.,"Retrospective evaluation of patients diagnosed solid pseudopapillary neoplasms of the pancreas.", CURRENT PROBLEMS IN CANCER, vol.-, 2018
Bellmunt J., De Wit R., Vaughn D.J., Fradet Y., Lee J.-., Fong L., et al.,"Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma", NEW ENGLAND JOURNAL OF MEDİCİNE, vol.376, pp.1015-1026, 2017 (Group Author(s): KEYNOTE-045 Investigators )
Aksoy A., Odabas H., Kaya S., Bozkurt O., Degirmenci M., Topcu T., et al., "Hormone receptor status and survival of medullary breast cancer patients. A Turkish cohort.", SAUDİ MEDİCAL JOURNAL, vol.38, pp.156-162, 2017
Gümüş M. , Bilici A., Odabas H., Ustaalioglu B., Kandemir N., Demirci U., et al., "Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors.", WORLD JOURNAL OF UROLOGY, vol.35, pp.1103-1110, 2017
Kaya S., Aktas B., Tanrikulu S.E., Akif O.M., Dede F., Kaya H., et al., "Changes in 18F-FDG-PET/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer.", JOURNAL OF BUON, vol.22, pp.1191-1198, 2017
Demirci A., Alkis N., Dane F., Durnalı A., Yazıcı Ö., Rzayev R., et al.,"Retrospective evaluation of premenopausal hormone-sensitive breast cancer patients treated with adjuvant gonadotropin-releasing hormone analogue: Anatolian Society of Medical Oncology (ASMO) study.", ASİA-PACİFİC JOURNAL OF CLİNİCAL ONCOLOGY, vol.-, 2017
Ercelep O., Topcu T., Bayoglu I., Ekinci A., Koca S., Kavgaci H., et al., "Retrospective multicenter evaluation of patients diagnosed with mucosal melanoma: a study of Anatolian Society of Medical Oncology.", TUMOR BIOLOGY, vol.37, pp.12033-12038, 2016
Ozcelik M., Korkmaz T., Odabas H., Gemici C., Ercelep O., Yuksel S., et al., "Comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patients", TUMOR BIOLOGY, vol.37, pp.8901-8907, 2016
Aydin D., Sendur M., Kefeli U., Unal O., Tastekin D., Akyol M., et al.,"Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection.", CLINICAL COLORECTAL CANCER, vol.-, 2016
Kaya S., Gümüş M. , Gurbuz Y., Cabuk D., Acikgoz O., Temiz S., et al., "The prognostic value of β-catenin and LEF-1 expression in patients with operable gastric carcinoma.", AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, vol.8, pp.1228-36, 2016
Dinc N., Aydın K., Odabas H., Ercelep O., Tufan G., Seker M., et al., "Pretreatment PET/CT Standardized Uptake Values Play a Role in Predicting Response to Treatment and Survival in Patients with Small Cell Lung Cancer.", ONCOLOGY RESEARCH AND TREATMENT, vol.39, pp.130-4, 2016
Ozcelik M., Odabas H., Ercelep O., Yuksel S., Mert A.G., Aydin D., et al., "The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients", CLINICAL & TRANSLATIONAL ONCOLOGY, vol.18, pp.617-624, 2016
Ozcelik M., Seker M., Eraslan E., Koca S., Yazilitas D., Ercelep O., et al., "Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology", TUMOR BIOLOGY, vol.37, pp.5231-5237, 2016
Yıldırım M., Kefeli U., Aydin D., Sener N., Gümüş M. , "The value of plasma netrin-1 in non-small cell lung cancer patients as diagnostic and prognostic biomarker.", TUMOR BIOLOGY, vol.37, pp.11903-11907, 2016
Aydin D., Ali S.M., Kefeli U., Umut U.O., Tastekin D., Akyol M., et al., "Evaluation of prognostic factors and treatment in advanced small bowel adenocarcinoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology (ASMO).", JOURNAL OF BUON, vol.21, pp.1242-1249, 2016
Aydin D., Sendur M., Kefeli U., Ustaalioglu B., Aydin O., Yildirim E., et al.,"Evaluation of Bevacizumab in Advanced Small Bowel Adenocarcinoma.", CLINICAL COLORECTAL CANCER, vol.-, 2016
Odabas H., Ulas A., Aydın K., Inanc M., Aksoy A., Yazilitas D., et al., "Is second-line systemic chemotherapy beneficial in patients with non-small cell lung cancer (NSCLC)? A multicenter data evaluation by the Anatolian Society of Medical Oncology.", TUMOR BIOLOGY, vol.36, pp.9641-8, 2015
Benekli M., Altundag K., Dumanli E., Isikdogan A., Karaoglu A., Tekin S.B., et al.,"Association of age with breast cancer clinical and pathological factors: Analysis of Turkish National Breast Cancer Registry.", JOURNAL OF CLINICAL ONCOLOGY, vol.33, 2015
Bilici A., Ozturk T., Turkmen E., Odabas H., Cihan S., Selcukbiricik F., et al., "Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology.", WORLD JOURNAL OF UROLOGY, vol.33, pp.1613-22, 2015
Gunes-Bayir A., Kiziltan H., Sentürk N., Mayadagli A., Gümüş M. , "A Pilot Study of Self-Reported Physical Activity and Eating Habits in Turkish Cancer Patients Under Chemotherapy.", NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, vol.67, pp.906-11, 2015
Bilici A., Sonkaya A., Ercan S., Ustaalioglu B., Seker M., Aliustaoglu M., et al., "The changing of serum vitamin B12 and homocysteine levels after gastrectomy in patients with gastric cancer: do they associate with clinicopathological factors?", TUMOR BIOLOGY, vol.36, pp.823-8, 2015
Kafadar D., Ince N., Akcakaya A., Gümüş M. , "Evaluation of Managerial Needs for Palliative Care Centers: Perspectives of Medical Directors.", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.16, pp.4653-8, 2015
Oven U.B., Bilici A., Yilmaz B., Aliustaoglu M., Seker M., Vardar F., et al., "Important Factors Affecting Adjuvant Treatment Decision in Stage IA Breast Cancer Patients in Turkey.", BREAST CARE, vol.9, pp.123-7, 2014
Bilici A., Inanc M., Ulas A., Akman T., Seker M., Babacan N., et al., "Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, pp.6493-9, 2014
Turan N., Benekli M., Dane F., Unal O., Kara H., Koca D., et al., "Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.", THORACIC CANCER, vol.5, pp.398-404, 2014
Gumusay O., Coskun U., Akman T., Ekinci A.S., Kocar M., Erceleb O.B., et al., "Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology", JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol.140, pp.151-157, 2014
Mehmet K., Sener C., Uyeturk U., Seker M., Tastekin D., Tonyali O., et al.,"Treatment modalities in primary gastric lymphoma: The effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology", WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, vol.18, pp.273-278, 2014
Mehmet K., Sener C., Uyeturk U., Seker M., Tastekin D., Tonyali O., et al., "Treatment modalities in primary gastric lymphoma: The effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology", WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, vol.18, pp.273-278, 2014
Mayadagli A., Karabulut G.S., Bilici A., Fatih O.A., Kocak M., Ozkan A., et al., "Prognostic significance of protein kinase B/Akt pathway in patients with non-small cell lung cancer.", JOURNAL OF BUON, vol.19, pp.157-63, 2014
Yalcin S., Gümüş M. , Kilickap S., Alkis N., Ilhan M., Oksuzoglu B., et al., "End-of-study results of Turkish gastric cancer patients from the global REGATE study", JOURNAL OF BUON, vol.19, pp.377-387, 2014
Korkmaz T., Seber S., Yavuzer D., Gümüş M. , Turhal N.S., "Primary renal carcinoid: Treatment and prognosis", CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, vol.87, pp.256-264, 2013
Korkmaz T., Seber S., Kefeli U., Sari E., Canhoroz M., Oven B., et al., "Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis", CLINICAL & TRANSLATIONAL ONCOLOGY, vol.15, pp.535-540, 2013
Ustaalioglu B.B.O., Bilici A., Ercan S., Seker M., Orcun A., Gümüş M. , "The prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer", MEDICAL ONCOLOGY, vol.30, 2013
Berk V., Kaplan M.A., Tonyali O., Buyukberber S., Balakan O., Ozkan M., et al., "Efficiency and Side Effects of Sorafenib Therapy for Advanced Hepatocellular Carcinoma: A Retrospective Study by the Anatolian Society of Medical Oncology", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, pp.7367-7369, 2013
Tonyali O., Coskun U., Sener N., Inanc M., Akman T., Ulas A., et al., "Prognostic Factors for Recurrence-Free Survival in Patients with HER2-Positive Early-Stage Breast Cancer Treated with Adjuvant Trastuzumab", ONKOLOGIE, vol.36, pp.554-558, 2013 (Group Author(s): ASMO )
Kefeli U., Benekli M., Sevinc A., Yildiz R., Kaplan M.A., Ciltas A., et al., "Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience", ONCOLOGY LETTERS, vol.6, pp.605-611, 2013
Kefeli U., Buyukberber S., Akyol M., Yildiz R., Kaplan M.A., Ciltas A., et al., "Efficacy of Sunitinib in Turkish Patients with Gastrointestinal Stromal Tumors; Retrospective Multicenter Experience", HEPATO-GASTROENTEROLOGY, vol.60, pp.647-652, 2013 (Group Author(s): Anatolian Soc Med Oncology ASMO )
Kaplan M.A., Isikdogan A., Gümüş M. , Arslan U.Y., Geredeli C., Ozdemir N., et al., "Childhood, Adolescents, and Young Adults (<= 25 y) Colorectal Cancer: Study of Anatolian Society of Medical Oncology", JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, vol.35, pp.83-89, 2013
Bilici A., Salman T., Ustaalioglu B.B.O., Unek T., Seker M., Aliustaoglu M., et al., "The prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomy", JOURNAL OF SURGICAL RESEARCH, vol.180, pp.E1-E9, 2013
Yetisyigit T., Arpaci E., Seber E.S., Kucukoner M., Kos F.T., Sonmez O.U., et al., "Salvage Treatment Experience in Advanced Synovial Sarcoma: a Multicenter Retrospective Analysis of the Anatolian Society of Medical Oncology", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, pp.5185-5188, 2013
Alici S., Buyukberber S., Alkis N., Benekli M., Ozkan M., Bilici A., et al., "Low-Dose Docetaxel/Cisplatin - Leucovorin and 46 Hour Infusional Fluorouracil in Metastatic Gastric Carcinoma", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, pp.423-427, 2013 (Group Author(s): Anatolian Soc Med Oncology )
Uygun K., Bilici A., Kaya S., Ustaalioglu B.B.O., Yildiz R., Temiz S., et al., "Xeliri Plus Bevacizumab Compared with Folfiri Plus Bevacizumab as First-Line Setting in Patients with Metastatic Colorectal Cancer: Experiences at Two-Institutions", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, pp.2283-2288, 2013
Ustaalioglu B.B.O., Unal O.U., Turan N., Bilici A., Kaya S., Eren T., et al., "Prognostic Factors for Lymph Node Negative Stage I and IIA Non-small Cell Lung Cancer: Multicenter Experiences", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.14, pp.6287-6292, 2013
Cetin B., Benekli M., Dane F., Boruban C., Gümüş M. , Oksuzoglu B., et al., "Lapatinib plus Capecitabine for HER2-Positive Advanced-Stage Breast Cancer in Elderly Women: Review of the Anatolian Society of Medical Oncology (ASMO) Experience", BREAST CARE, vol.8, pp.67-70, 2013
Seker M., Sevinc A., Yildiz R., Cihan S., Kaplan M.A., Gokdurnali A., et al., "Prognostic Factors in Gastrointestinal Stromal Tumors: Multicenter Experience of 333 Cases from Turkey", HEPATO-GASTROENTEROLOGY, vol.60, pp.768-775, 2013
Ustaalioglu B.B.O., Ulas A., Esbah O., Turan N., Bilici A., Demirci U., et al., "Large cell neuroendocrine carcinoma: retrospective analysis of 24 cases from four oncology centers in Turkey", THORACIC CANCER, vol.4, pp.161-166, 2013 (Group Author(s): ASMO )
Ustaalioglu B.O., Bilici A., Kefeli U., Seker M., Oncel M., Gezen C., et al., "The Importance of Multifocal/Multicentric Tumor on the Disease-Free Survival of Breast Cancer Patients Single Center Experience", AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, vol.35, pp.580-586, 2012
Inal A., Ciltas A., Yildiz R., Berk V., Kos F.T., Dane F., et al., "Long Term Survivors with Metastatic Pancreatic Cancer Treated with Gemcitabine Alone or Plus Cisplatin: a Retrospective Analysis of an Anatolian Society of Medical Oncology Multicenter Study", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.13, pp.1841-1844, 2012
Gümüş M. , Davidson N., Bauknecht T., Soldatenkova V., Benhadji K.A., "Taxane-based mono- or combination therapy for managing metastatic breast cancer (MBC) in routine practice: a multinational prospective observational study", CURRENT MEDICAL RESEARCH AND OPINION, vol.28, pp.401-413, 2012
Arslan U.Y., Oksuzoglu B., Ozdemir N., Aksoy S., Alkis N., Gok A., et al., "Outcome of non-metastatic male breast cancer: 118 patients", MEDICAL ONCOLOGY, vol.29, pp.554-560, 2012
Bilici A., Ustaalioglu B.B.O., Yavuzer D., Seker M., Mayadagli A., Gümüş M. , "Prognostic Significance of High Phosphatase of Regenerating Liver-3 Expression in Patients with Gastric Cancer Who Underwent Curative Gastrectomy", DIGESTIVE DISEASES AND SCIENCES, vol.57, pp.1568-1575, 2012
Ustaalioglu B.O., Bilici A., Ercan S., Orcun A., Seker M., Ozkan A., et al., "Serum M30 and M65 values in patients with advanced stage non-small-cell lung cancer compared with controls", CLINICAL & TRANSLATIONAL ONCOLOGY, vol.14, pp.356-361, 2012
Inal A., Kos F.T., Algin E., Yildiz R., Dikiltas M., Unek I.T., et al., "Gemcitabine Alone versus combination of Gemcitabine and Cisplatin for the Treatment of Patients with Locally Advanced and/or Metastatic Pancreatic Carcinoma: A Retrospective Analysis of multicenter study", NEOPLASMA, vol.59, pp.297-301, 2012
Kefeli U., Yildirim M.E., Aydin D., Madenci O.C., Yasar N., Sener N., et al., "Netrin-1 concentrations in patients with advanced gastric cancer and its relation with treatment", BIOMARKERS, vol.17, pp.663-667, 2012
Tonyali O., Coskun U., Sener N., Inanc M., Akman T., Oksuzoglu B., et al., "Nine-week trastuzumab treatment versus 52-week trastuzumab treatment for HER2-positive early-stage breast cancer", JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, vol.138, pp.2145-2151, 2012 (Group Author(s): ASMO )
Ustaalioglu B.B.O., Bilici A., Barisik N.O., Aliustaoglu M., Vardar F.A., Yilmaz B.E., et al., "Clinical importance of phosphatase of regenerating liver-3 expression in breast cancer", CLINICAL & TRANSLATIONAL ONCOLOGY, vol.14, pp.911-922, 2012
Bilici A., Seker M., Oven Ustaalioglu B.B., Hallac Keser S., Cinaral F., Gümüş M. , "Gallbladder metastasis secondary to gastric cancer as a first site of recurrence presented with acute cholecystitis: Case report and literature review", TURKISH JOURNAL OF GASTROENTEROLOGY, vol.23, pp.764-768, 2012
Kaya A.O., Coskun U., Ozkan M., Sevinc A., Yilmaz A.U., Gümüş M. , et al., "Paclitaxel plus Doxorubicin Chemotherapy as Second-Line Therapy in Patients with Advanced Urothelial Carcinoma Pretreated with Platinum plus Gemcitabine Chemotherapy", ONKOLOGIE, vol.35, pp.576-580, 2012 (Group Author(s): ASMO )
Eser M., Kement M., Balin S., Coskun C., Kefeli U., Gümüş M. , et al., "Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer", WORLD JOURNAL OF SURGICAL ONCOLOGY, vol.10, 2012
Kaya A.O., Coskun U., Gümüş M. , Dane F., Ozkan M., Isikdogan A., et al., "The efficacy and toxicity of irinotecan with leucovorin and bolus and continuous infusional 5-fluorouracil (FOLFIRI) as salvage therapy for patients with advanced gastric cancer previously treated with platinum and taxane-based chemotherapy regimens", JOURNAL OF CHEMOTHERAPY, vol.24, pp.217-220, 2012 (Group Author(s): ASMO )
Mayadagli A., Kocak M., Demir O., Gul S.K., Ozkan A., Parlak C., et al., "Elective bladder preservation with multimodality treatment for bladder cancer", JOURNAL OF BUON, vol.17, pp.483-489, 2012
Inal A., Kos F.T., Algin E., Yildiz R., Berk V., Unek I.T., et al., "Prognostic factors in patients with advanced pancreatic cancer treated with gemcitabine alone or gemcitabine plus cisplatin: retrospective analysis of a multicenter study", JOURNAL OF BUON, vol.17, pp.102-105, 2012 (Group Author(s): Anatolian Soc Med Oncology )
Gezen C., Kement M., Altuntas Y.E., Okkabaz N., Seker M., Vural S., et al., "Results after multivisceral resections of locally advanced colorectal cancers: an analysis on clinical and pathological t4 tumors", WORLD JOURNAL OF SURGICAL ONCOLOGY, vol.10, 2012
Altinbas M., Kalender M.E., Oven B., Sevinc A., Karaca H., Kaplan M.A., et al., "Weekly Topotecan for Recurrent Small Cell Lung Cancer - a Retrospective Anatolian Medical Oncology Group Study", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.13, pp.2909-2912, 2012
Bilici A., Ustaalioglu B.B.O., Ercan S., Seker M., Yilmaz B.E., Orcun A., et al., "The prognostic significance of the increase in the serum M30 and M65 values after chemotherapy and relationship between these values and clinicopathological factors in patients with advanced gastric cancer", TUMOR BIOLOGY, vol.33, pp.2201-2208, 2012
Ozkan M., Berk V., Kaplan M.A., Benekli M., Coskun U., Bilici A., et al., "Gemcitabine and Cisplatin Combination Chemotherapy in Triple Negative Metastatic Breast Cancer Previously Treated with a Taxane/Anthracycline Chemotherapy; Multicenter Experience", NEOPLASMA, vol.59, pp.38-42, 2012
Bilici A., Yapici H.S., Ercan S., Seker M., Ustaalioglu B.B.O., Salman T., et al., "The prevalence and significance of autoantibodies in patients with non-Hodgkin's lymphoma: are they correlated with clinicopathological features?", JOURNAL OF BUON, vol.17, pp.502-507, 2012
Bilici A., Dane F., Seker M., Ustaalioglu B.B.O., Aliustaoglu M., Temiz S., et al., "Is Subdivision of pT2 Tumors Superior to Lymph Node Metastasis for Predicting Survival of Patients with Gastric Cancer? Review of 224 Patients from Four Centers", DIGESTIVE DISEASES AND SCIENCES, vol.56, pp.3226-3234, 2011
Alkis N., Demirci U., Benekli M., Yilmaz U., Isikdogan A., Sevinc A., et al., "Mitomycin-C in combination with fluoropyrimidines in the treatment of metastatic colorectal cancer after oxaliplatin and irinotecan failure", JOURNAL OF BUON, vol.16, pp.80-83, 2011 (Group Author(s): Anatolian Soc Med Oncology ASMO )
Barisik N.O., Keser S.H., Gul A.E., Sensu S., Kandemir N.O., Küçük H.F., et al., "The value of COX-2 expression in the prognostic parameters of invasive ductal carcinoma of the breast", MEDICAL ONCOLOGY, vol.28, pp.703-708, 2011
Kefeli U., Kaya S., Ustaalioglu B.O., Bilici A., Kefeli A.U., Yildirim M.E., et al., "Prognostic factors in elderly patients with non-small cell lung cancer: a two-center experience", MEDICAL ONCOLOGY, vol.28, pp.661-666, 2011
Kefeli U., Bilici A., Ustaalioglu B.B.O., Kefeli A.U., Yildirim M.E., Seker M., et al., "A case of metastatic breast cancer successfully treated with lapatinib plus capecitabine therapy", ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.283, pp.405-407, 2011
Ustaalioglu B.B.O., Seker M., Bilici A., Canpolat N., Yildirim E., Kefeli U., et al., "The role of PET-CT in the differential diagnosis of thymic mass after treatment of patients with lymphoma", MEDICAL ONCOLOGY, vol.28, pp.258-264, 2011
Bilici A., Ustaalioglu B.B.O., Ercan S., Orcun A., Seker M., Salepçi T., et al., "Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?", CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol.68, pp.309-316, 2011
Seker M., Bilici A., Ustaalioglu B.O., Yilmaz B., Ozturk B., Unal A., et al., "Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breast", ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.284, pp.405-409, 2011
Basaran G., Turhal N.S., Cabuk D., Yurt N., Yurtseven G., Gümüş M. , et al., "Weight gain after adjuvant chemotherapy in patients with early breast cancer in Istanbul Turkey", MEDICAL ONCOLOGY, vol.28, pp.409-415, 2011
Sevinc A., Seker M., Bilici A., Ozdemir N.Y., Yildiz R., Ustaalioglu B.O., et al., "Co-existence of Gastrointestinal Stromal Tumors with Other Primary Neoplasms", HEPATO-GASTROENTEROLOGY, vol.58, pp.824-830, 2011
Sonmez B., Seker M., Bilici A., Erkal F.Y., Ustaalioglu B.B.O., Gümüş M. , et al., "Is there any correlation among adiponectin levels in serum, tumor tissue and normal tissue of the same patients with breast cancer?", JOURNAL OF BUON, vol.16, pp.227-232, 2011
Bilici A., Ustaalioglu B.B.O., Seker M., Kefeli U., Canpolat N., Tekinsoy B., et al., "The role of F-18-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients' treatment decision making?", EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol.38, pp.64-73, 2011
Mayadagli A., Aksu A., Goksel F., Gocen E., Karahacioglu E., Gümüş M. , et al., "DETERMINATION OF PARAMETERS AFFECTING THE USE OF COMPLEMENTARY AND ALTERNATIVE MEDICINE IN CANCER PATIENTS AND DETECTION OF PREVALENCE OF USE", AFRICAN JOURNAL OF TRADITIONAL COMPLEMENTARY AND ALTERNATIVE MEDICINES, vol.8, pp.477-482, 2011
Seker M., Bilici A., Guler D.O., Ustaalioglu B.B., Gozu H., Erkal F.Y., et al., "Tissue and Serum Adiponectin Levels in Patients with Gastric Cancer: Are there any Correlations between Adiponectin Levels and Histopathological Variables?", HEPATO-GASTROENTEROLOGY, vol.58, pp.1841-1846, 2011
Ustaalioglu B.B.O., Bilici A., Kefeli U., Seker M., Salepci T., Unal O., et al., "A retrospective analysis of women's chances to become pregnant after completion of chemotherapy: a single center experience", JOURNAL OF BUON, vol.16, pp.349-352, 2011
Bilici A., Seker M., Ustaalioglu B.B.O., Canpolat N., Salepçi T., Gümüş M. , "Pulmonary BALT Lymphoma Successfully Treated with Eight Cycles Weekly Rituximab: Report of First Case and F-18 FDG PET/CT Images", JOURNAL OF KOREAN MEDICAL SCIENCE, vol.26, pp.574-576, 2011
Dane F., Ozturk M.A., Gümüş M. , Guven A., Aliustaoglu M., Cabuk D., et al., "Efficacy, safety and prognostic features of resected colon carcinoma treated in "real world" practice: a retrospective cohort-study", JOURNAL OF BUON, vol.16, pp.257-264, 2011
Gezen C., Altuntas Y.E., Kement M., Okkabaz N., Bilici A., Vural S., et al., "Laparoscopic Abdominoperineal Resections for Mid or Low Rectal Adenocarcinomas: A Retrospective, Comparative Study", SURGICAL LAPAROSCOPY ENDOSCOPY TECHNIQUES, vol.21, pp.396-402, 2011
Seker M., Ozdemir B., Bilici A., Ustaalioglu B.B., Sönmez B., Yilmaz B.E., et al., "Bilateral Conjunctival MALT Lymphoma Mimicking Chronic Conjunctivitis", ONKOLOGIE, vol.33, pp.317-320, 2010
Ustaalioglu B.B.O., Bilici A., Kefeli U., Seker M., Yildirim E., Salepçi T., et al., "Does the Metastatic Lymph Node Ratio Influence the Disease-Free Survival of Patients with Breast Cancer: Single-Center Experiences", ONCOLOGY, vol.79, pp.105-111, 2010
Bilici A., Ustaalioglu B.B.O., Gümüş M. , Seker M., Yilmaz B., Kefeli U., et al., "Is Metastatic Lymph Node Ratio Superior to the Number of Metastatic Lymph Nodes to Assess Outcome and Survival of Gastric Cancer?", ONKOLOGIE, vol.33, pp.101-105, 2010
Karagoz B., Bilgi O., Gümüş M. , Erikci A.A., Sayan O., Turken O., et al., "CD8+CD28-cells and CD4+CD25+regulatory T cells in the peripheral blood of advanced stage lung cancer patients", MEDICAL ONCOLOGY, vol.27, pp.29-33, 2010
Aliustaoglu M., Bilici A., Ustaalioglu B.B.O., Konya V., Gucun M., Seker M., et al., "The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment", MEDICAL ONCOLOGY, vol.27, pp.1060-1065, 2010
Yumuk P.F., Kefeli U., Ceyhan B., Dane F., Eroglu B.T., Gümüş M. , et al., "Pulmonary toxicity in patients receiving docetaxel chemotherapy", MEDICAL ONCOLOGY, vol.27, pp.1381-1388, 2010
Bilici A., Bilici A., Ustaalioglu B.B.O., Seker M., Canpolat N., Gümüş M. , "F-18 FDG PET/CT imaging in recurrent mantle cell lymphoma presenting with cauda equina syndrome", CLINICAL NUCLEAR MEDICINE, vol.35, pp.211-212, 2010
Bilici A., Seker M., Ustaalioglu B.B.O., Kefeli U., Yildirim E., Yavuzer D., et al., "Prognostic Significance of Perineural Invasion in Patients with Gastric Cancer Who Underwent Curative Resection", ANNALS OF SURGICAL ONCOLOGY, vol.17, pp.2037-2044, 2010
Bilici A., Seker M., Ustaalioglu B.B.O., Yilmaz B., Doventas A., Salepçi T., et al., "Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer", MEDICAL ONCOLOGY, vol.27, pp.975-984, 2010
Ustaalioglu B.B.O., Gümüş M. , Bilici A., Seker M., Ustaalioglu R., Kefeli U., et al., "Is there a cut-off value for standardized uptake values in positron emission tomography for predicting response to treatment and survival in patients with advanced non-small cell lung cancer? Single center experience", JOURNAL OF BUON, vol.15, pp.529-536, 2010
Bilici A., Ustaalioglu B.B.O., Seker M., Canpolat N., Tekinsoy B., Salepçi T., et al., "Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?", EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol.37, pp.1259-1269, 2010
Seker M., Ustaalioglu B.B.O., Bilici A., Yildirim M.E., Kefeli U., Barisik N.O., et al., "Eight-cycle rituximab therapy resulted in complete remission in primary cutaneous marginal zone lymphoma", LEUKEMIA RESEARCH, vol.34, pp.E160-E163, 2010
Ustaalioglu B.B.O., Gümüş M. , Unal A., Cayir K., Sever O., Bilici A., et al., "Malignancies Diagnosed During Pregnancy and Treated With Chemotherapy or Other Modalities (Review of 27 Cases) Multicenter Experiences", INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, vol.20, pp.698-703, 2010
Aliustaoglu M., Bilici A., Gümüş M. , Colak A.T., Baloglu G., Irmak R., et al., "Preoperative serum leptin levels in patients with breast cancer", MEDICAL ONCOLOGY, vol.27, pp.388-391, 2010
Ustaalioglu B.B.O., Gümüş M. , Bilici A., Seker M., Dane F., Salepçi T., et al., "Neoadjuvant chemotherapy for locally advanced breast cancer: a single center experience", MEDICAL ONCOLOGY, vol.27, pp.454-458, 2010
Kaya A.O., Buyukberber S., Dane F., Isikdogan A., Ustaalioglu B.O., Coskun U., et al., "Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancer", TUMORI, vol.96, pp.400-404, 2010 (Group Author(s): ASMO )
Aliustaoglu M., Bilici A., Seker M., Dane F., Gocun M., Konya V., et al., "The Association of Pre-treatment Peripheral Blood Markers with Survival in Patients with Pancreatic Cancer", HEPATO-GASTROENTEROLOGY, vol.57, pp.640-645, 2010
Sezen O.S., Eraslan G., Coskuner T., Yavuzer D., Bilici A., Bilge S., et al., "Endometrial Adenocarcinoma Metastasis to Nasal Skin", JOURNAL OF OTOLARYNGOLOGY-HEAD SURGERY, vol.39, pp.E8-E11, 2010
Barisik N.O., Bozkurt S., Gümüş M. , Kaygusuz I., Karadayi N., Bas E., et al., "Expression and prognostic significance of cox-2 and p-53 in hodgkin lymphomas: a retrospective study", DIAGNOSTIC PATHOLOGY, vol.5, 2010
Gümüş M. , Ustaalioglu B.O., Garip M., Kiziltan E., Bilici A., Seker M., et al., "Factors that Affect Patients' Decision-Making about Mastectomy or Breast Conserving Surgery, and the Psychological Effect of this Choice on Breast Cancer Patients", BREAST CARE, vol.5, pp.164-168, 2010
Seker M., Bilici A., Sönmez B., Ustaalioglu B.B.O., Gümüş M. , Gozu H., et al., "The association of serum adiponectin levels with histopathological variables in gastric cancer patients", MEDICAL ONCOLOGY, vol.27, pp.1319-1323, 2010
Bilici A., Salepçi T., Dane F., Gümüş M. , Ustaalioglu B.B.O., Seker M., et al., "Neoadjuvant chemotherapy followed by interval cytoreductive surgery in patients with unresectable, advanced stage epithelial ovarian cancer: a single centre experience", ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.282, pp.417-425, 2010
Salepçi T., Seker M., Uyarel H., Gümüş M. , Bilici A., Ustaalioglu B.B.O., et al., "5-Fluorouracil induces arterial vasoconstrictions but does not increase angiotensin II levels", MEDICAL ONCOLOGY, vol.27, pp.416-420, 2010
Ustaalioglu B.B.O., Bilici A., Seker M., Canpolat N., Ozdemir N., Salepçi T., et al., "Primary non-Hodgkin lymphoma of cervix successfully treated with rituximab: Positron emission tomography images before and after therapy: A case report", LEUKEMIA RESEARCH, vol.34, pp.E108-E110, 2010
Bilici A., Uygun K., Seker M., Ustaalioglu B.B.O., Aliustaoglu M., Temiz S., et al., "The Effect of Tumor Size on Overall Survival in Patients with pT3 Gastric Cancer: Experiences from 3 Centers", ONKOLOGIE, vol.33, pp.676-682, 2010
Salman T., Seker M., Bilici A., Ustaalioglu B.B., Gümüş M. , Yaylaci M., "Lung cancer presenting with extreme leukocytosis", JOURNAL OF BUON, vol.15, pp.193-193, 2010
Oven B.B.U., Bilici A., Seker M., Salepci T., Keser S., Gümüş M. , "Renal cell carcinoma with pulmonary metastasis misdiagnosed as other primary malignant tumor", JOURNAL OF BUON, vol.14, pp.727-728, 2009
Seker M., Ustaalioglu B.B., Bilici A., Ozseker N.I., Aksu A., Gümüş M. , "Acute renal failure and multiple extranodal involvement in a patient with diffuse large B cell lymphoma", JOURNAL OF BUON, vol.14, pp.726-727, 2009
Kocak M., Ozkan A., Mayadagli A., Parlak C., Bilici A., Bilici A., et al., "Induction chemotherapy and chemoradiation therapy for inoperable locally advanced non-small-cell lung cancer: A single-institution review of two different regimens", CLINICAL LUNG CANCER, vol.10, pp.124-129, 2009
Alici S., Coskun U., Alkış N., Sevinc A., Dane F., Gümüş M. , et al., "Vinorelbine in combination with carboplatin followed by single-agent consolidation therapy for unresectable localized or metastatic non-small-cell lung carcinomas", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.10, pp.1051-1056, 2009
Karaoglu A., Arslan U.Y., Ozkan M., Kalender M.E., Alici S., Coskun U., et al., "Efficacy and Toxicity of Gemcitabine and Pegylated Liposomal Doxorubicin in Recurrent Platinum-Resistant/Refractory Epithelial Ovarian Cancer", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.10, pp.63-66, 2009 (Group Author(s): Anatolian Soc Med Oncology )
Ustaalioglu B.B.O., Bilici A., Seker M., Salman T., Gümüş M. , Barisik N.O., et al., "Metastasis of Lobular Breast Carcinoma to the Uterus in a Patient under Anastrozole Therapy", ONKOLOGIE, vol.32, pp.424-426, 2009
Salepci T., Seker M., Kurnaz E., Guler D., Bilici A., Dane F., et al., "Conjunctival malt lymphoma successfully treated with single agent rituximab therapy", LEUKEMIA RESEARCH, vol.33, pp.1-1, 2009
Demirhan R., Mayadagli A., Parlak C., Kocak M., Ozkan A., Gümüş M. , "Our resection outcome in lung cancer: Evaluation of 45 consequential patients", JOURNAL OF CLINICAL ONCOLOGY, vol.26, 2008
Kaya A.O., Coskun U., Unlu M., Akdemir U.O., Ozdemir N.Y., Zengin N., et al., "Whole Body 18F-FDG PET/CT Imaging in the Detection of Primary Tumours in Patients with a Metastatic Carcinoma of Unknown Origin", ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, vol.9, pp.683-686, 2008 (Group Author(s): Anatolian Soc Med Oncology )
Bilgi O., Karagoz B., Turken O., Kandemir E.G., Ozturk A., Gümüş M. , et al., "Peripheral blood gamma-delta T cells in advanced-stage cancer patients", ADVANCES IN THERAPY, vol.25, pp.218-224, 2008
Koldas M., Gümüş M. , Seker M., Seval H., Karaoglu H., Dane F., et al., "Thrombin-activatable fibrinolysis inhibitor levels in patients with non-small-cell lung cancer", CLINICAL LUNG CANCER, vol.9, pp.112-115, 2008
Kocak M., Mayadagli A., Ozkan A., Parlak C., Demir O., Marti A., et al., "Outcome of metastatic non-small cell lung carcinoma patients receiving docetaxel-cisplatin combination chemotherapy: single institution experience", JOURNAL OF BUON, vol.12, pp.471-476, 2007
Sakar B., Gümüş M. , Basaran M., Argon A., Ustuner Z., Ustaoglu M.A., et al., "XELOX followed by XELIRI or the reverse sequence in advanced colorectal cancer", ONCOLOGY, vol.73, pp.298-304, 2007
Gümüş M. , Yumuk P.F., Salepci T., Aliustaoglu M., Dane F., Ekenel M., et al., "HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples", JOURNAL OF EXPERIMENTAL CANCER RESEARCH, vol.25, pp.515-521, 2006
Gümüş M. , Yumuk P., Atalay G., Aliustaoglu M., Macunluoglu B., Dane F., et al., "What is the optimal number of lymph nodes to be dissected in colorectal cancer surgery?", TUMORI, vol.91, pp.168-172, 2005
Yumuk P., Abacioglu U., Demir G., Cabuk D., Dane F., Gümüş M. , et al., "Does the incidence of anal canal cancers differ in Moslem societies?", INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, vol.20, pp.76-76, 2005
Yumuk P., Turhal N., Gümüş M. , Hatabay N., Turken O., Ozkan A., et al., "Results of paclitaxel (day 1 and 8) and carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung cancer", BMC CANCER, vol.5, 2005
Turhal N., Dane F., Dede F., Gümüş M. , Yumuk P., Cakalagaoglu F., et al., "99m-Tc-MDP-scintimammography in the evaluation of breast masses or tumor angiogenesis", ANTICANCER RESEARCH, vol.24, pp.1999-2006, 2004
Aliustaoglu M., Yumuk P., Gümüş M. , Ekenel M., Bolukbas F., Bolukbas C., et al., "D-dimer - Can it be a marker for malignant gastric lesions?", ACTA ONCOLOGICA, vol.43, pp.770-771, 2004
Yumuk P., Aydin S., Dane F., Gümüş M. , Ekenel M., Aliustaoglu M., et al., "The absence of early diarrhea with atropine premedication during irinotecan therapy in metastatic colorectal patients", INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, vol.19, pp.609-610, 2004
Bolukbas F., Kilic H., Bolukbas C., Gümüş M. , Horoz M., Turhal N., et al., "Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study", BMC CANCER, vol.4, 2004
Sakar B., Karagol H., Gümüş M. , Basaran M., Kaytan E., Argon A., et al., "Timing of death from tumor recurrence after curative gastrectomy for gastric cancer", AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, vol.27, pp.205-209, 2004
Yumuk P., Gümüş M. , Ekenel M., Basaran G., Aliustaoglu M., Topal A., et al., "Attitude toward genetic testing for cancer risk in Istanbul", GENETIC TESTING, vol.8, pp.169-173, 2004
Bolukbas F., Bolukbas C., Horoz M., Gümüş M. , Erdogan M., Zeyrek F., et al., "Child-Pugh classification dependent alterations in serum leptin levels among cirrhotic patients: a case controlled study", BMC GASTROENTEROLOGY, vol.4, 2004
Yumuk P., Abacioglu U., Caglar H., Gümüş M. , Sengoz M., Turhal N., "Outcome of rectal and sigmoid carcinoma patients receiving adjuvant chemoradiotherapy in marmara university hospital", JOURNAL OF CHEMOTHERAPY, vol.15, pp.603-606, 2003
Turhal N.S., Aliustaoglu M., Gurses A., Gümüş M. , Atalay G., Karamanoglu A., et al., "Neoplastic diseases prevalence in a turkish university hospital", JOURNAL OF BUON, vol.8, pp.45-48, 2003
Turk-Boru U., Kocer A., Alp R., Gumus M., Gümüş M. , "Status epilepticus in a case of Wilson's disease during D-pencillamine treatment", SWISS MEDICAL WEEKLY, vol.133, pp.446-447, 2003
Turhal N., Efe B., Gümüş M. , Aliustaoglu M., Karamanoglu A., Sengoz M., "Patient satisfaction in the outpatients' chemotherapy unit of Marmara University, Istanbul, Turkey: a staff survey.", BMC CANCER, vol.2, pp.30-30, 2002
Turhal N.S., Gümüş M. , Atalay G., Aliustaoglu M., Kabakas F., Karamanoglu A., et al., "Outpatient cancer care in a Turkish University hospital", JOURNAL OF BUON, vol.7, pp.397-398, 2002